Literature DB >> 8994895

The Empirical Behavioral Pathology in Alzheimer's Disease (E-BEHAVE-AD) Rating Scale.

S R Auer1, I M Monteiro, B Reisberg.   

Abstract

A clinician should not rely entirely upon a caregiver's report regarding behavioral pathology when planning a treatment strategy. Direct observational evaluation instruments as well as caregiver-based assessments are necessary. A new scale for the empirical (observational) evaluation of behavioral symptoms in Alzheimer's disease (AD) and related dementias, the Empirical Behavioral Pathology in Alzheimer's Disease Rating Scale (E-BEHAVE-AD) was developed. Interrater reliability of this new assessment instrument was examined. Additionally, the relationship between the observed occurrence of behavioral symptomatology on this new rating instrument was compared with the occurrence using a similarly designed, caregiver-based instrument. The interrater reliability study consisted of two raters who simultaneously evaluated 20 dementia patients. The comparative study employed a cross-sectional design (N = 49). Individuals were evaluated in an outpatient clinic setting. The study population consisted of cognitively normal individuals and dementia patients. Evaluations included the new, observationally based behavioral assessment (the E-BEHAVE-AD), a caregiver-based behavioral assessment (the Behavioral Pathology in Alzheimer's Disease Rating Scale; BEHAVE-AD), a clinical global measure (the Global Deterioration Scale), and a mental status assessment (the Mini-Mental State Examination). The interrater reliability study revealed an intraclass correlation coefficient of .97 (p < .01) for total scores on the new E-BEHAVE-AD rating scale. The correlation coefficient for the amount of agreement on the presence of symptoms in six symptomatic categories between caregiver-based information about the patient's behavioral pathology assessed on the BEHAVE-AD and the clinician's observations assessed with the new E-BEHAVE-AD rating instrument was .51 (p < .01). The new E-BEHAVE-AD rating instrument showed excellent interrater reliability. Furthermore, there was a statistically significant relationship between clinician observation of the occurrence of behavioral pathology assessed using the E-BEHAVE-AD and caregiver-reported pathology assessed with the BEHAVE-AD. However, the magnitude of the correlation between these measures indicated that the majority of variance was independent and nonoverlapping. Consequently, these data support theoretical models suggesting that the assessment of behavioral pathology in dementia might ideally encompass both direct observational and caregiver-report approaches, using measures such as the E-BEHAVE-AD as well as measures such as the BEHAVE-AD.

Entities:  

Mesh:

Year:  1996        PMID: 8994895     DOI: 10.1017/s1041610296002621

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  15 in total

Review 1.  The Diagnosis and Treatment of Behavioral Disorders in Dementia.

Authors:  Torsten Kratz
Journal:  Dtsch Arztebl Int       Date:  2017-06-30       Impact factor: 5.594

2.  A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia.

Authors:  Zahinoor Ismail; Chetachi A Emeremni; Patricia R Houck; Sati Mazumdar; Jules Rosen; Tarek K Rajji; Bruce G Pollock; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-02       Impact factor: 4.105

Review 3.  The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical review.

Authors:  Barry Reisberg; Isabel Monteiro; Carol Torossian; Stefanie Auer; Melanie B Shulman; Santosh Ghimire; Istvan Boksay; Francoise Guillo BenArous; Ricardo Osorio; Aninditha Vengassery; Sheema Imran; Hussam Shaker; Sadaf Noor; Shazia Naqvi; Sunnie Kenowsky; Jinfeng Xu
Journal:  Dement Geriatr Cogn Disord       Date:  2014-04-07       Impact factor: 2.959

Review 4.  Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.

Authors:  Laura N Gitlin; Katherine A Marx; Ian H Stanley; Bryan R Hansen; Kimberly S Van Haitsma
Journal:  Int Psychogeriatr       Date:  2014-08-06       Impact factor: 3.878

Review 5.  Anxiety in dementia: a critical review.

Authors:  Paul J Seignourel; Mark E Kunik; Lynn Snow; Nancy Wilson; Melinda Stanley
Journal:  Clin Psychol Rev       Date:  2008-03-07

6.  An approach to and the rationale for the pharmacological management of behavioral and psychological symptoms of dementia.

Authors:  Manjari Tripathi; Deepti Vibha
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

7.  Dementia service centres in Austria: A comprehensive support and early detection model for persons with dementia and their caregivers - theoretical foundations and model description.

Authors:  Stefanie R Auer; Edith Span; Barry Reisberg
Journal:  Dementia (London)       Date:  2013-10-17

8.  The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis.

Authors:  Taro Kishi; Shinji Matsunaga; Nakao Iwata
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-20       Impact factor: 2.570

9.  DEMDATA: The Austrian-Czech institutional long term care project - design and protocol of a two-centre cross sectional study.

Authors:  Stefanie Auer; Elisabeth Linsmayer; Anna Beránková; Patrick Pascher; Bernadette Firlinger; Doris Prischl; Paulina Ratajczak; Edith Span; Iva Holmerova
Journal:  BMC Health Serv Res       Date:  2017-04-20       Impact factor: 2.655

Review 10.  Assessment of neuropsychiatric symptoms in dementia: toward improving accuracy.

Authors:  Florindo Stella
Journal:  Dement Neuropsychol       Date:  2013 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.